HYALURONIC ACID GEL AND PHOTOBIOMODULATION FOR CHRONIC GENERALIZED PERIODONTITIS IN PATIENTS WITH CHRONIC LEUKEMIA

Authors

  • Marupova Madina Khikmatulloyevna Assistant, Department of Restorative Dentistry, Samarkand State Medical University, Samarkand, Uzbekistan

Keywords:

periodontitis; chronic lymphocytic leukemia; chronic myeloid leukemia; hyaluronic acid; low-level light therapy; photobiomodulation; secretory immunoglobulin A; muramidase

Abstract

Chronic leukemia causes secondary immunodeficiency that aggravates chronic generalized periodontitis and limits the response to conventional therapy. This prospective non-randomized controlled study evaluated hyaluronic acid gel combined with 660-nm photobiomodulation as an adjunct to non-surgical periodontal therapy. A total of 125 patients with chronic leukemia and periodontitis received standard therapy (n=63) or standard therapy plus the adjuncts (n=62), and 30 healthy subjects served as controls. At baseline, patients showed 35% lower salivary sIgA, reduced lysozyme activity and Ca/P ratio, and a higher subgingival bacterial load than controls (p<0.001). By day 90, the adjunctive group achieved greater pocket depth reduction (2.5 vs 1.1 mm), higher sIgA and lower bacterial load than the standard group (all p<0.001), and the composite treatment response was 64.5% vs 28.6%. No serious adverse events occurred. Adjunctive hyaluronic acid with photobiomodulation was safe and improved short-term outcomes of periodontitis in chronic leukemia.

References

1.Kassebaum NJ, Bernabé E, Dahiya M, Bhandari B, Murray CJ, Marcenes W. Global burden of severe periodontitis in 1990–2010: a systematic review and meta-regression. J Dent Res. 2014;93(11):1045–53. doi:10.1177/0022034514552491

2.World Health Organization. Global oral health status report: towards universal health coverage for oral health by 2030. Geneva: WHO; 2022.

3.Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018;89(Suppl 1):S173–S182. doi:10.1002/JPER.17-0721

4.Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159–S172. doi:10.1002/JPER.18-0006

5.Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15(1):30–44. doi:10.1038/nri3785

6.Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. doi:10.1038/nrdp.2017.38

7.Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukaemia. Br Med Bull. 2008;87:49–62. doi:10.1093/bmb/ldn034

8.Hallek M, Cheson BD, Catovsky D, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745–60. doi:10.1182/blood-2017-09-806398

9.Hochhaus A, Baccarani M, Silver RT, et al. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020;34(4):966–84. doi:10.1038/s41375-020-0776-2

10.Rinčić N, Božić D, Rinčić G, Gaćina P, Plančak D. Evaluation of periodontal parameters in patients with early stage chronic lymphocytic leukemia. Acta Stomatol Croat. 2016;50(1):23–33. doi:10.15644/asc50/1/4

11.Busjan R, Hasenkamp J, Schmalz G, Haak R, Trümper L, Ziebolz D. Oral health status in adult patients with newly diagnosed acute leukemia. Clin Oral Investig. 2018;22(1):411–8.

12.Ptasiewicz M, Maksymiuk P, Chałas R. Oral hygiene considerations in adult patients with leukemia during a cycle of chemotherapy. Int J Environ Res Public Health. 2022;19(1):479. doi:10.3390/ijerph19010479

13.Elad S, Raber-Durlacher JE, Brennan MT, et al. Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of MASCC/ISOO and EBMT. Support Care Cancer. 2015;23(1):223–36. doi:10.1007/s00520-014-2378-x

14.Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I–III periodontitis — the EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(Suppl 22):4–60. doi:10.1111/jcpe.13290

15.Eick S, Renatus A, Heinicke M, Pfister W, Stratul SI, Jentsch H. Hyaluronic acid as an adjunct after scaling and root planing: a prospective randomized clinical trial. J Periodontol. 2013;84(7):941–9. doi:10.1902/jop.2012.120269

16.Eliezer M, Imber JC, Sculean A, Pandis N, Teich S. Hyaluronic acid as adjunctive to non-surgical and surgical periodontal therapy: a systematic review and meta-analysis. Clin Oral Investig. 2019;23(9):3423–35. doi:10.1007/s00784-019-03012-w

17.Dahiya P, Kamal R. Hyaluronic acid: a boon in periodontal therapy. N Am J Med Sci. 2013;5(5):309–15. doi:10.4103/1947-2714.112473

18.Niemczyk W, Matys J, Wiench R, Żurek J, Dominiak M. The use of hyaluronic acid in the non-surgical treatment of periodontitis — an umbrella review. Biomedicines. 2025;13(4):998. doi:10.3390/biomedicines13040998

19.Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337–61. doi:10.3934/biophy.2017.3.337

20.Zadik Y, Arany PR, Fregnani ER, et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3969–83. doi:10.1007/s00520-019-04890-2

21.Elad S, Cheng KKF, Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423–31. doi:10.1002/cncr.33100

22.Ren C, McGrath C, Jin L, Zhang C, Yang Y. The effectiveness of low-level laser therapy as an adjunct to non-surgical periodontal treatment: a meta-analysis. J Periodontal Res. 2017;52(1):8–20. doi:10.1111/jre.12361

23.Salvi GE, Stähli A, Schmidt JC, Ramseier CA, Sculean A, Walter C. Adjunctive laser or antimicrobial photodynamic therapy to non-surgical mechanical instrumentation in patients with untreated periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):176–98. doi:10.1111/jcpe.13236

24.Des Jarlais DC, Lyles C, Crepaz N; TREND Group. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94(3):361–6. doi:10.2105/ajph.94.3.361

25.World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4. doi:10.1001/jama.2013.281053

26.Greene JC, Vermillion JR. The simplified oral hygiene index. J Am Dent Assoc. 1964;68:7–13.

27.Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J. 1982;32(3):281–91.

28.Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134–44.

29.Brandtzaeg P. Secretory immunity with special reference to the oral cavity. J Oral Microbiol. 2013;5:20401. doi:10.3402/jom.v5i0.20401

30.Laheij AM, de Soet JJ. Can the oral microflora affect oral ulcerative mucositis? Curr Opin Support Palliat Care. 2014;8(2):180–7.

Published

2026-10-30